Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


New Amedeo service:

Amedeo COVID-19 (formerly 2019-nCoV)

Weekly publication summary


  Colorectal Neoplasms

  Free Subscription


Articles published in Br J Surg

Retrieve available abstracts of 66 articles:
HTML format
Text format



Single Articles


    February 2020
  1. KOBAYASHI M, Kako J, Kajiwara K, Oosono Y, et al
    Comment on: Predicting return to work among patients with colorectal cancer.
    Br J Surg. 2020;107:318.
    PubMed     Text format    


    January 2020
  2. ALMAZEEDI S, El-Abd R, Al-Khamis A, Albatineh AN, et al
    Role of bariatric surgery in reducing the risk of colorectal cancer: a meta-analysis.
    Br J Surg. 2020 Jan 24. doi: 10.1002/bjs.11494.
    PubMed     Text format     Abstract available


  3. SCHAAP DP, de Valk KS, Deken MM, Meijer RPJ, et al
    Carcinoembryonic antigen-specific, fluorescent image-guided cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for metastatic colorectal cancer.
    Br J Surg. 2020 Jan 21. doi: 10.1002/bjs.11523.
    PubMed     Text format     Abstract available


  4. SARASTE D, Jaras J, Martling A
    Population-based analysis of outcomes with early-age colorectal cancer.
    Br J Surg. 2020 Jan 10. doi: 10.1002/bjs.11333.
    PubMed     Text format     Abstract available


  5. XU YJ, Sun X, Jiang H, Yin YH, et al
    Randomized clinical trial of continuous transversus abdominis plane block, epidural or patient-controlled analgesia for patients undergoing laparoscopic colorectal cancer surgery.
    Br J Surg. 2020;107:e133-e141.
    PubMed     Text format     Abstract available


    November 2019
  6. WATT SK, Fransgaard T, Degett TH, Thygesen LC, et al
    Associations between blood cultures after surgery for colorectal cancer and long-term oncological outcomes.
    Br J Surg. 2019 Nov 22. doi: 10.1002/bjs.11372.
    PubMed     Text format     Abstract available


    October 2019
  7. DEN BAKKER CM, Anema JR, Huirne JAF, Twisk J, et al
    Predicting return to work among patients with colorectal cancer.
    Br J Surg. 2019 Oct 25. doi: 10.1002/bjs.11313.
    PubMed     Text format     Abstract available


  8. ZABOROWSKI A, Stakelum A, Winter DC
    Author response to: Total neoadjuvant therapy in rectal cancer-improvement or overtreatment?
    Br J Surg. 2019;106:1558.
    PubMed     Text format    


  9. MROCZKOWSKI P, Dziki L
    Total neoadjuvant therapy in rectal cancer - improvement or overtreatment?
    Br J Surg. 2019;106:1558.
    PubMed     Text format    


    August 2019
  10. GARLIPP B, Gibbs P, Van Hazel GA, Jeyarajah R, et al
    Secondary technical resectability of colorectal cancer liver metastases after chemotherapy with or without selective internal radiotherapy in the randomized SIRFLOX trial.
    Br J Surg. 2019 Aug 19. doi: 10.1002/bjs.11283.
    PubMed     Text format     Abstract available


  11. LARSEN SG, Pfeffer F, Korner H
    Norwegian moratorium on transanal total mesorectal excision.
    Br J Surg. 2019;106:1120-1121.
    PubMed     Text format    


  12. PUCCIARELLI S, Del Bianco P, Pace U, Bianco F, et al
    Multicentre randomized clinical trial of colonic J pouch or straight stapled colorectal reconstruction after low anterior resection for rectal cancer.
    Br J Surg. 2019;106:1147-1155.
    PubMed     Text format     Abstract available


  13. ERLANDSSON J, Pettersson D, Glimelius B, Holm T, et al
    Postoperative complications in relation to overall treatment time in patients with rectal cancer receiving neoadjuvant radiotherapy.
    Br J Surg. 2019;106:1248-1256.
    PubMed     Text format     Abstract available


  14. BACHET JB, Moreno-Lopez N, Vigano L, Marchese U, et al
    BRAF mutation is not associated with an increased risk of recurrence in patients undergoing resection of colorectal liver metastases.
    Br J Surg. 2019;106:1237-1247.
    PubMed     Text format     Abstract available


    July 2019
  15. ROTTIER SJ, van Dijk ST, van Geloven AAW, Schreurs WH, et al
    Meta-analysis of the role of colonoscopy after an episode of left-sided acute diverticulitis.
    Br J Surg. 2019;106:988-997.
    PubMed     Text format     Abstract available


  16. LAKKIS Z, Vernerey D, Mege D, Faucheron JL, et al
    Morbidity and oncological outcomes of rectal cancer impaired by previous prostate malignancy.
    Br J Surg. 2019;106:1087-1098.
    PubMed     Text format     Abstract available


  17. ZABOROWSKI A, Stakelum A, Winter DC
    Systematic review of outcomes after total neoadjuvant therapy for locally advanced rectal cancer.
    Br J Surg. 2019;106:979-987.
    PubMed     Text format     Abstract available


  18. AMELUNG FJ, Borstlap WAA, Consten ECJ, Veld JV, et al
    Propensity score-matched analysis of oncological outcome between stent as bridge to surgery and emergency resection in patients with malignant left-sided colonic obstruction.
    Br J Surg. 2019;106:1075-1086.
    PubMed     Text format     Abstract available


    June 2019
  19. BEDNARSKI BK, Nickerson TP, You YN, Messick CA, et al
    Randomized clinical trial of accelerated enhanced recovery after minimally invasive colorectal cancer surgery (RecoverMI trial).
    Br J Surg. 2019 Jun 19. doi: 10.1002/bjs.11223.
    PubMed     Text format     Abstract available


  20. SILLO TO, Beggs AD, Morton DG, Middleton G, et al
    Mechanisms of immunogenicity in colorectal cancer.
    Br J Surg. 2019 Jun 19. doi: 10.1002/bjs.11204.
    PubMed     Text format     Abstract available


  21. HAMID HKS
    Correspondence.
    Br J Surg. 2019;106:949-950.
    PubMed     Text format    


  22. DUCHALAIS E, Larson DW
    Correspondence.
    Br J Surg. 2019;106:950-951.
    PubMed     Text format    



  23. Snapshot quiz.
    Br J Surg. 2019;106:836.
    PubMed     Text format    


  24. QUIRAM BJ, Crippa J, Grass F, Lovely JK, et al
    Impact of enhanced recovery on oncological outcomes following minimally invasive surgery for rectal cancer.
    Br J Surg. 2019;106:922-929.
    PubMed     Text format     Abstract available


    May 2019
  25. SHINKINS B, Primrose JN, Pugh SA, Nicholson BD, et al
    Serum carcinoembryonic antigen trends for diagnosing colorectal cancer recurrence in the FACS randomized clinical trial.
    Br J Surg. 2019;106:728.
    PubMed     Text format    


  26. WESTBERG K, Palmer G, Hjern F, Holm T, et al
    Population-based study of surgical treatment with and without tumour resection in patients with locally recurrent rectal cancer.
    Br J Surg. 2019;106:790-798.
    PubMed     Text format     Abstract available


  27. VAN DER POEL MJ, Barkhatov L, Fuks D, Berardi G, et al
    Multicentre propensity score-matched study of laparoscopic versus open repeat liver resection for colorectal liver metastases.
    Br J Surg. 2019;106:783-789.
    PubMed     Text format     Abstract available


    April 2019
  28. REYNOLDS IS, Furney SJ, Kay EW, McNamara DA, et al
    Meta-analysis of the molecular associations of mucinous colorectal cancer.
    Br J Surg. 2019 Apr 4. doi: 10.1002/bjs.11142.
    PubMed     Text format     Abstract available


  29. KEANE C, Park J, Oberg S, Wedin A, et al
    Functional outcomes from a randomized trial of early closure of temporary ileostomy after rectal excision for cancer.
    Br J Surg. 2019;106:645-652.
    PubMed     Text format     Abstract available


    March 2019
  30. ABIS GSA, Stockmann HBAC, Bonjer HJ, van Veenendaal N, et al
    Randomized clinical trial of selective decontamination of the digestive tract in elective colorectal cancer surgery (SELECT trial).
    Br J Surg. 2019;106:355-363.
    PubMed     Text format     Abstract available



  31. Snapshot quiz.
    Br J Surg. 2019;106:341.
    PubMed     Text format    


  32. KELLER DS, Reali C, Spinelli A, Penna M, et al
    Patient-reported functional and quality-of-life outcomes after transanal total mesorectal excision.
    Br J Surg. 2019;106:364-366.
    PubMed     Text format     Abstract available


  33. LAU YC, Jongerius K, Wakeman C, Heriot AG, et al
    Influence of the level of sacrectomy on survival in patients with locally advanced and recurrent rectal cancer.
    Br J Surg. 2019;106:484-490.
    PubMed     Text format     Abstract available


  34. VAN 'T SANT I, van Eden WJ, Engbersen MP, Kok NFM, et al
    Diffusion-weighted MRI assessment of the peritoneal cancer index before cytoreductive surgery.
    Br J Surg. 2019;106:491-498.
    PubMed     Text format     Abstract available


  35. AHL R, Matthiessen P, Fang X, Cao Y, et al
    Effect of beta-blocker therapy on early mortality after emergency colonic cancer surgery.
    Br J Surg. 2019;106:477-483.
    PubMed     Text format     Abstract available


    February 2019
  36. SEGELMAN J, Buchli C, Svanstrom Rojvall A, Matthiessen P, et al
    Effect of radiotherapy for rectal cancer on ovarian androgen production.
    Br J Surg. 2019;106:267-275.
    PubMed     Text format    


    January 2019
  37. BJORNELV GMW, Dueland S, Line PD, Joranger P, et al
    Cost-effectiveness of liver transplantation in patients with colorectal metastases confined to the liver.
    Br J Surg. 2019;106:132-141.
    PubMed     Text format     Abstract available


  38. ELFEKI H, Larsen HM, Emmertsen KJ, Christensen P, et al
    Bowel dysfunction after sigmoid resection for cancer and its impact on quality of life.
    Br J Surg. 2019;106:142-151.
    PubMed     Text format     Abstract available


    November 2018
  39. KOSKENVUO L, Malila N, Pitkaniemi J, Miettinen J, et al
    Sex differences in faecal occult blood test screening for colorectal cancer.
    Br J Surg. 2018 Nov 21. doi: 10.1002/bjs.11011.
    PubMed     Text format     Abstract available


    August 2018
  40. BARE M, Mora L, Tora N, Gil MJ, et al
    CCR-CARESS score for predicting operative mortality in patients with colorectal cancer.
    Br J Surg. 2018 Aug 13. doi: 10.1002/bjs.10956.
    PubMed     Text format     Abstract available


  41. MARGONIS GA, Sasaki K, Gholami S, Kim Y, et al
    Genetic And Morphological Evaluation (GAME) score for patients with colorectal liver metastases.
    Br J Surg. 2018;105:1210-1220.
    PubMed     Text format     Abstract available


  42. OKUNO M, Goumard C, Mizuno T, Kopetz S, et al
    Prognostic impact of perihepatic lymph node metastases in patients with resectable colorectal liver metastases.
    Br J Surg. 2018;105:1200-1209.
    PubMed     Text format     Abstract available


    May 2018

  43. Advanced colorectal cancer issue.
    Br J Surg. 2018;105:E240-E247.
    PubMed     Text format    


  44. BROWN KGM, Solomon MJ
    Progress and future direction in the management of advanced colorectal cancer.
    Br J Surg. 2018;105:615-617.
    PubMed     Text format    


  45. PASSOT G, Dumont F, Goere D, Arvieux C, et al
    Multicentre study of laparoscopic or open assessment of the peritoneal cancer index (BIG-RENAPE).
    Br J Surg. 2018;105:663-667.
    PubMed     Text format     Abstract available


  46. YAMASHITA S, Chun YS, Kopetz SE, Vauthey JN, et al
    Biomarkers in colorectal liver metastases.
    Br J Surg. 2018;105:618-627.
    PubMed     Text format     Abstract available



  47. Factors affecting outcomes following pelvic exenteration for locally recurrent rectal cancer.
    Br J Surg. 2018;105:650-657.
    PubMed     Text format     Abstract available


    April 2018
  48. QUYN AJ, Fraser CG, Rodger J, Digan A, et al
    Participation in bowel screening among men attending abdominal aortic aneurysm screening.
    Br J Surg. 2018;105:529-534.
    PubMed     Text format     Abstract available


    March 2018
  49. SHINKINS B, Primrose JN, Pugh SA, Nicholson BD, et al
    Serum carcinoembryonic antigen trends for diagnosing colorectal cancer recurrence in the FACS randomized clinical trial.
    Br J Surg. 2018 Mar 26. doi: 10.1002/bjs.10819.
    PubMed     Text format     Abstract available


  50. DUELAND S, Foss A, Solheim JM, Hagness M, et al
    Survival following liver transplantation for liver-only colorectal metastases compared with hepatocellular carcinoma.
    Br J Surg. 2018 Mar 13. doi: 10.1002/bjs.10769.
    PubMed     Text format     Abstract available


  51. VAN ZOGGEL DMGI, Bosman SJ, Kusters M, Nieuwenhuijzen GAP, et al
    Preliminary results of a cohort study of induction chemotherapy-based treatment for locally recurrent rectal cancer.
    Br J Surg. 2018;105:447-452.
    PubMed     Text format     Abstract available


    February 2018
  52. PARK J, Danielsen AK, Angenete E, Bock D, et al
    Quality of life in a randomized trial of early closure of temporary ileostomy after rectal resection for cancer (EASY trial).
    Br J Surg. 2018;105:244-251.
    PubMed     Text format     Abstract available


  53. GRUT H, Solberg S, Seierstad T, Revheim ME, et al
    Growth rates of pulmonary metastases after liver transplantation for unresectable colorectal liver metastases.
    Br J Surg. 2018;105:295-301.
    PubMed     Text format     Abstract available


    January 2018
  54. ESCAL L, Nougaret S, Guiu B, Bertrand MM, et al
    MRI-based score to predict surgical difficulty in patients with rectal cancer.
    Br J Surg. 2018;105:140-146.
    PubMed     Text format     Abstract available


  55. UBINK I, van Eden WJ, Snaebjornsson P, Kok NFM, et al
    Histopathological and molecular classification of colorectal cancer and corresponding peritoneal metastases.
    Br J Surg. 2018;105:e204-e211.
    PubMed     Text format     Abstract available


  56. MARKS KM, West NP, Morris E, Quirke P, et al
    Clinicopathological, genomic and immunological factors in colorectal cancer prognosis.
    Br J Surg. 2018;105:e99-e109.
    PubMed     Text format     Abstract available


  57. RYAN EJ, Creagh EM
    Emerging methods in colorectal cancer screening.
    Br J Surg. 2018;105:e16-e18.
    PubMed     Text format    


  58. GAINES S, Shao C, Hyman N, Alverdy JC, et al
    Gut microbiome influences on anastomotic leak and recurrence rates following colorectal cancer surgery.
    Br J Surg. 2018;105:e131-e141.
    PubMed     Text format     Abstract available


  59. KOYAMA FC, Lopes Ramos CM, Ledesma F, Alves VAF, et al
    Effect of Akt activation and experimental pharmacological inhibition on responses to neoadjuvant chemoradiotherapy in rectal cancer.
    Br J Surg. 2018;105:e192-e203.
    PubMed     Text format     Abstract available


    December 2017
  60. WESTBERG K, Palmer G, Hjern F, Nordenvall C, et al
    Population-based study of factors predicting treatment intention in patients with locally recurrent rectal cancer.
    Br J Surg. 2017;104:1866-1873.
    PubMed     Text format     Abstract available


    November 2017
  61. CREAVIN B, Kelly ME, Ryan E, Winter DC, et al
    Meta-analysis of the impact of surgical approach on the grade of mesorectal excision in rectal cancer.
    Br J Surg. 2017;104:1609-1619.
    PubMed     Text format     Abstract available


  62. DIEDEREN K, Sahami SS, Tabbers MM, Benninga MA, et al
    Outcome after restorative proctocolectomy and ileal pouch-anal anastomosis in children and adults.
    Br J Surg. 2017;104:1640-1647.
    PubMed     Text format     Abstract available


    October 2017
  63. NITSCHE U, Stoss C, Stecher L, Wilhelm D, et al
    Meta-analysis of outcomes following resection of the primary tumour in patients presenting with metastatic colorectal cancer.
    Br J Surg. 2017 Oct 31. doi: 10.1002/bjs.10682.
    PubMed     Text format     Abstract available


  64. ELLEBAEK SB, Fristrup CW, Hovendal C, Qvist N, et al
    Randomized clinical trial of laparoscopic ultrasonography before laparoscopic colorectal cancer resection.
    Br J Surg. 2017;104:1462-1469.
    PubMed     Text format     Abstract available


    February 2017
  65. MARTLING A, Smedby KE, Birgisson H, Olsson H, et al
    Risk of second primary cancer in patients treated with radiotherapy for rectal cancer.
    Br J Surg. 2017;104:278-287.
    PubMed     Text format     Abstract available


  66. HAIN E, Maggiori L, Manceau G, Mongin C, et al
    Oncological impact of anastomotic leakage after laparoscopic mesorectal excision.
    Br J Surg. 2017;104:288-295.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Colorectal Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: